A sales representative reported in behalf of the customer that on (b)(6) 2020, the a1114 mayfield infinity skull clamp rocker arm detached.The physician attempted to apply torque pressure and then decided to reposition the patient.After releasing the torque pressure and attempting to remove the rocker arm, the rocker arm detached from the base unit.The patient was repositioned and pinned.No patient injury and delay in surgery reported.
|
Additional information: device identifier #: (b)(4).The device was returned for evaluation.The unit was received without the pedi rocker arm and the black suitcase.The unit had lateral and rotational movement due to residue build up in the lock.Pm maintenance and cleaning required at this time.The device history record (dhr) was reviewed with no abnormalities related to the reported failure.The device passed all required inspection points with no associated mrr¿s, variances or rework.The reported complaint was not confirmed.The unit arrived without the rocker arm, which had been removed.The torque knob read correctly.No manufacturing, workmanship, or material deficiency has been identified.Between 05nov2019 and 30jun2020, approximately 2,200 mdrs submitted electronically by integra lifesciences via trackwise, integra's complaint handling system, were not received by cdrh due to a computer system issue.Within this time period, an error with integra's middleware, which facilitates communications between trackwise and the fda system, caused the complaint records to close and indicate we had received an acknowledgement 3 from the fda when we had not.Integra interpreted the acknowledgement as a successful submission; however, subsequent investigation revealed the acknowledgement 3 received was from our middleware and not from the fda (these acknowledgements have been retained as part of the documentation of the mdr).The malfunction was related to the relocation of the trackwise application to a new data center during the transition of integra's corporate headquarters from plainsboro, nj to princeton, nj.Previously, integra had been successfully receiving acknowledgements 1, 2, and 3 from the fda, and our records reflect these acknowledgements, including the date and time stamps.Capa pr 229048 and nc 20-011 have been opened by integra to further investigate the nonconformance and develop a corrective action plan.The middleware error has been corrected, and integra has filed mdrs since the correction and verified that the appropriate acknowledgements have been received from the fda.Integra is resubmitting all impacted mdr reports for the time period 05nov2019 through 30jun2020.Integra lifesciences contacted (b)(4), director of regulatory programs, office of product evaluation and quality and (b)(4), assistant director, mdr team, office of product evaluation and quality on july 8-9, 2020 to report these issues regarding mdr reports.
|